Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol

Clinical trial NCT00390624 · COMPLETED

Trial details

NCT number: NCT00390624
Sponsor: Rocky Mountain Cancer Centers
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Dysfunction Acute Renal Failure Mortality

Start date: 2003-07-01
Primary completion: 2006-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.